Hair has always been more than just a style—especially in the Black community, where our coils, curls, and protective styles ...

Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...

The delay in Sun Pharma's launch of Leqselvi in the US was caused by a patent infringement case, which was later settled in a ...

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

Knowing what to avoid when you have alopecia areata may help prevent hair loss. ... and processed meat consumption related to inflammatory and metabolic biomarkers among overweight and obese women.

Patients share what they wish they had known before getting a diagnosis of alopecia areata, an autoimmune disease that causes hair loss.

Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...

Patients with higher-severity alopecia areata (AA) have a higher prevalence and incidence of comorbid atopic dermatitis (AD), ...

Alopecia areata was more likely to develop in patients with inflammatory bowel ... (n = 59) and the control cohort (n = 90) had primarily women participants (47.5% vs 53.3%). Similar types of ...

Mumbai: Sun Pharmaceutical Industries Limited has announced the launch of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S.